Publications by authors named "Magdalena A Ogrodnik"
Front Neurol
January 2018
Article Synopsis
- DMF is a promising treatment for relapsing-remitting multiple sclerosis (MS), but its exact mechanism of action is still unclear.
- Understanding how DMF affects lymphocyte subsets and its clinical efficacy could help improve monitoring and the development of future MS therapies.
- Research shows that DMF reduces lymphocyte counts, especially impacting CD8 T-cells and promoting a shift towards a more anti-inflammatory immune response, but its specific effects within the central nervous system of MS patients remain largely unexplored.
